Literature DB >> 7536119

Detection of Helicobacter pylori infection in early stage gastric cancer. A comparison between intestinal- and diffuse-type gastric adenocarcinomas.

S Endo1, T Ohkusa, Y Saito, K Fujiki, I Okayasu, C Sato.   

Abstract

BACKGROUND: Helicobacter pylori (H pylori) infection has been suggested to be a risk factor for gastric carcinogenesis. However, those previous studies have been concerned with advanced cancer cases. To the authors' knowledge, no detailed investigation on the prevalence of H pylori in early stage gastric cancer tissue has been performed. The relationship between early stage gastric cancer and the prevalence of H pylori was studied by a immunohistochemical staining analysis.
METHODS: Sixty-eight patients who were endoscopically and surgically diagnosed as having early stage gastric cancer were enrolled in this study. All tissue specimens were obtained from patients by endoscopic biopsy, and were classified histopathologically as the intestinal-type of early stage gastric cancer in 34 patients (male-to-female ratio, 28:6; age, 64 +/- 11 years) and the diffuse-type of early stage gastric cancer (male-to-female ratio, 23:11; age, 57 +/- 14 years) in the other 34 patients. The amount of H pylori in tissue samples was graded from 0 (no characteristic bacteria) to 3 (numerous bacteria) using the fluorescent microscopic and an immunohistochemical technique.
RESULTS: Twenty-nine of the 34 cases of the intestinal-type of gastric cancer had H pylori infection, as compared with 11 of the 34 cases of diffuse-type early stage gastric cancer. A significantly higher incidence (85%; P < 0.001) of H pylori infection and, thus, higher grading scores of the number of H pylori were found in the intestinal-type early stage gastric cancer.
CONCLUSIONS: These findings suggest that the infection of H pylori may have a crucial relationship to the early stages of carcinogenesis of intestinal-type gastric cancer.

Entities:  

Mesh:

Year:  1995        PMID: 7536119     DOI: 10.1002/1097-0142(19950501)75:9<2203::aid-cncr2820750903>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Helicobacter pylori and mucosal atrophy in patients with gastric cancer: a special study regarding the methods for detecting Helicobacter pylori.

Authors:  H Tabata; T Fuchigami; H Kobayashi; Y Sakai; M Nakanishi; K Tomioka; S Nakamura; M Fujishima
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

2.  Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma.

Authors:  J Rudi; C Kolb; M Maiwald; I Zuna; A von Herbay; P R Galle; W Stremmel
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

3.  Helicobacter pylori infection in patients with early gastric cancer by the endoscopic phenol red test.

Authors:  K Iseki; M Tatsuta; H Iishi; M Baba; S Ishiguro
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

4.  Cell surface glycosaminoglycans are not involved in the adherence of Helicobacter pylori to cultured Hs 198.St human gastric cells, Hs 746T human gastric adenocarcinoma cells, or HeLa cells.

Authors:  H Kawasaki; G Sugumaran; J E Silbert
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

5.  Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma.

Authors:  C N Chen; C T Sung; M T Lin; P H Lee; K J Chang
Journal:  Ann Surg       Date:  2001-02       Impact factor: 12.969

6.  Serological Immunoglobulin G antibody titers to Helicobacter pylori in Japanese Brazilian and Non-Japanese Brazilian gastric cancer patients and controls in São Paulo.

Authors:  N Fujioka; M T Fahey; G S Hamada; I N Nishimoto; L P Kowalski; K Iriya; J J Rodrigues; H Tajiri; S Tsugane
Journal:  Jpn J Cancer Res       Date:  2001-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.